26-A-10534-ACC ARE WE UNDERESTIMATING THE CLINICAL IMPACT OF MAVACAMTEN IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY? NEW INSIGHTS FROM REAL-WORLD GLOBAL DATA